Procalcitonin to Predict Bacterial Coinfection in Infants With Acute Bronchiolitis
- 1 January 2014
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pediatric Emergency Care
- Vol. 30 (1), 11-15
- https://doi.org/10.1097/pec.0000000000000026
Abstract
Objective The aim of this study was to conduct a preliminary analysis of serum procalcitonin (PCT) to predict bacterial coinfection in infants with acute bronchiolitis. Methods Retrospective cohort chart review of 40 infants admitted with acute bronchiolitis to the pediatric intensive care unit. Logistic regression models were used to determine the association of PCT and white blood count with presence of bacterial coinfection defined by either positive culture or chest radiograph result. Results Fifteen (38%) of 40 patients had a diagnosis of bacterial coinfection by positive culture (9/15) or chest radiograph (6/15). Procalcitonin (P < 0.0001) was significantly associated with bacterial coinfection. A cutoff value of 1.5 ng/mL had sensitivity of 0.80, specificity of 1.00, and area under the operating curve of 0.88. White blood count (P = 0.06) was borderline significant with sensitivity of 0.33, specificity of 0.96, and area under the operating curve of 0.67. Three of 15 patients were later found to have bacterial coinfection with initial PCT of less than 1.5 ng/mL. None had follow-up PCT measurements taken. Thirty-five of 40 were prescribed empiric antibiotic therapy, including 20 of 25 patients without evidence of bacterial coinfection. None had a PCT of greater than 1.5 ng/mL. If a PCT cutoff of greater than 1.5 ng/mL had been used, 57% fewer patients would have received antibiotics with a 45% reduction in antimicrobial charges. Conclusions An elevated PCT may assist clinicians in determining presence of bacterial coinfection at admission in infants with acute bronchiolitis. Implementation of a PCT cutoff of 1.5 ng/mL at admission may prevent unnecessary antibiotic use with associated cost savings. Serial PCT levels may increase sensitivity. Further validation is warranted.Keywords
This publication has 36 references indexed in Scilit:
- Incidence of bacterial coinfection with respiratory syncytial virus bronchopulmonary infection in pediatric inpatientsJournal of Infection and Chemotherapy, 2011
- Bronchiolitis: Recent Evidence on Diagnosis and ManagementPublished by American Academy of Pediatrics (AAP) ,2010
- A prospective randomized controlled blinded study of three bronchodilators in infants with respiratory syncytial virus bronchiolitis on mechanical ventilation*Pediatric Critical Care Medicine, 2008
- A Multicenter, Randomized, Controlled Trial of Dexamethasone for BronchiolitisNew England Journal of Medicine, 2007
- Procalcitonin to Reduce the Number of Unnecessary Cystographies in Children with a Urinary Tract Infection: A European Validation StudyThe Journal of Pediatrics, 2007
- Direct Medical Costs of Bronchiolitis Hospitalizations in the United StatesPEDIATRICS, 2006
- Diagnosis and Management of BronchiolitisPediatrics, 2006
- Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infectionThe Journal of Pediatrics, 2003
- Serum procalcitonin in cerebral ventriculitisCritical Care Medicine, 2002
- Procalcitonin as a marker of bacterial infectionThe Pediatric Infectious Disease Journal, 2000